Boston Scientific Corporation
BSX
Israeli Tech Ecosystem Related
Company Overview
Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Urology and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979, and is headquartered in Marlborough, MA.
Shariah Compliance Benchmarks:
- Business Compliance: Non-Shariah compliant revenue must be less than 5% of total revenue
- Liabilities Compliance: Interest-bearing debt must be less than 33% of market capitalization
This stock meets all Shariah compliance criteria according to AAOIFI standards.
| Revenue Segment | Value ($M) | Non-Compliant ($M) | Reason |
|---|---|---|---|
| MedSurg | $5,057.0 | $0.0 | - |
| Cardiovascular | $8,161.0 | $0.0 | - |
| Total | $13,218.0 | $0.0 | 0.00% (passed) |
| Name | Boston Scientific Corporation |
| Ticker | BSX |
| Main Business | Medical devices |
| Type | Securities |
| Industry | Medical Devices |
| Country | US |
| Market Cap | $84.98 B |
Rythmia
Founded: 2004
Cardiac arrhythmia treatment solutions
SoniVie
Founded: 2014
Pulmonary Hypertension Denervation Treatment
VeinWay
Founded: 2020
Advanced Vein Blockage Crossing Tools
